These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24559811)

  • 21. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial.
    Ko SJ; Ryu B; Kim J; Hong BG; Yeo I; Lee BJ; Lee JM; Park JW
    Trials; 2011 Oct; 12():219. PubMed ID: 21978382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients.
    Mangel AW; Chaturvedi P
    Digestion; 2008; 78(4):180-6. PubMed ID: 19092244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.
    Brinkhaus B; Hentschel C; Von Keudell C; Schindler G; Lindner M; Stützer H; Kohnen R; Willich SN; Lehmacher W; Hahn EG
    Scand J Gastroenterol; 2005 Aug; 40(8):936-43. PubMed ID: 16173134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin.
    Bossi P; Cortinovis D; Fatigoni S; Cossu Rocca M; Fabi A; Seminara P; Ripamonti C; Alfieri S; Granata R; Bergamini C; Agustoni F; Bidoli P; Nolè F; Pessi MA; Macchi F; Michellini L; Montanaro F; Roila F
    Ann Oncol; 2017 Oct; 28(10):2547-2551. PubMed ID: 28666335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
    J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
    Ahluwalia B; Magnusson MK; Böhn L; Störsrud S; Larsson F; Savolainen O; Ross A; Simrén M; Öhman L
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13860. PubMed ID: 32314514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial.
    Zheng L; Lai Y; Lu W; Li B; Fan H; Yan Z; Gong C; Wan X; Wu J; Huang D; Wang Y; Mei Y; Li Z; Jiang Z; Liu X; Ye J; Yang Y; Huang H; Xiao J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1285-1292.e1. PubMed ID: 25632806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial.
    Das AD; Ghosh S; Palanisamy C; Guha N; Mandal S; Maiti S; Nath A; Singh NK; Koley M; Saha S
    Explore (NY); 2023; 19(4):519-527. PubMed ID: 36307315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
    World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
    Nordin E; Brunius C; Landberg R; Hellström PM
    Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
    Tuteja AK; Fang JC; Al-Suqi M; Stoddard GJ; Hale DC
    Scand J Gastroenterol; 2012 Oct; 47(10):1159-64. PubMed ID: 22783919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial.
    Miryan M; Alavinejad P; Abbaspour M; Soleimani D; Ostadrahimi A
    Trials; 2020 Aug; 21(1):698. PubMed ID: 32758282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
    Fukudo S; Nakajima A; Fujiyama Y; Kosako M; Nakagawa A; Akiho H; Nakashima Y; Johnston JM; Miwa H
    Neurogastroenterol Motil; 2018 May; 30(5):e13275. PubMed ID: 29278278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
    J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.